CDTX
Price
$16.35
Change
-$1.47 (-8.25%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
195.19M
RNAC
Price
$9.98
Change
-$2.36 (-19.12%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
319.69M
Ad is loading...

CDTX vs RNAC

Header iconCDTX vs RNAC Comparison
Open Charts CDTX vs RNACBanner chart's image
Cidara Therapeutics
Price$16.35
Change-$1.47 (-8.25%)
Volume$1.39K
Capitalization195.19M
Cartesian Therapeutics
Price$9.98
Change-$2.36 (-19.12%)
Volume$2.29K
Capitalization319.69M
CDTX vs RNAC Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. RNAC commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and RNAC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (CDTX: $17.82 vs. RNAC: $12.34)
Brand notoriety: CDTX and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 136% vs. RNAC: 103%
Market capitalization -- CDTX: $195.19M vs. RNAC: $319.69M
CDTX [@Biotechnology] is valued at $195.19M. RNAC’s [@Biotechnology] market capitalization is $319.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than RNAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 3 TA indicator(s) are bullish while RNAC’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 3 bullish, 5 bearish.
  • RNAC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CDTX and RNAC are a bad buy in the short-term.

Price Growth

CDTX (@Biotechnology) experienced а -17.42% price change this week, while RNAC (@Biotechnology) price change was -14.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 13, 2024.

RNAC is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($320M) has a higher market cap than CDTX($195M). RNAC YTD gains are higher at: -31.100 vs. CDTX (-33.705). RNAC has higher annual earnings (EBITDA): -75.99M vs. CDTX (-175.87M). RNAC has more cash in the bank: 213M vs. CDTX (190M). CDTX has less debt than RNAC: CDTX (3.58M) vs RNAC (14M). RNAC has higher revenues than CDTX: RNAC (38.9M) vs CDTX (1.28M).
CDTXRNACCDTX / RNAC
Capitalization195M320M61%
EBITDA-175.87M-75.99M231%
Gain YTD-33.705-31.100108%
P/E RatioN/AN/A-
Revenue1.28M38.9M3%
Total Cash190M213M89%
Total Debt3.58M14M26%
FUNDAMENTALS RATINGS
CDTX vs RNAC: Fundamental Ratings
CDTX
RNAC
OUTLOOK RATING
1..100
8263
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4390
P/E GROWTH RATING
1..100
10035
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (48) in the Biotechnology industry is somewhat better than the same rating for RNAC (99). This means that CDTX’s stock grew somewhat faster than RNAC’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that CDTX’s stock grew similarly to RNAC’s over the last 12 months.

CDTX's SMR Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that CDTX’s stock grew similarly to RNAC’s over the last 12 months.

CDTX's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for RNAC (90). This means that CDTX’s stock grew somewhat faster than RNAC’s over the last 12 months.

RNAC's P/E Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for CDTX (100). This means that RNAC’s stock grew somewhat faster than CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXRNAC
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
82%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 9 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 9 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Ad is loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.99%
WINT - CDTX
94%
Closely correlated
-11.51%
NBY - CDTX
93%
Closely correlated
-1.70%
NCNA - CDTX
93%
Closely correlated
-5.57%
SNPX - CDTX
93%
Closely correlated
-4.22%
BPTSY - CDTX
92%
Closely correlated
N/A
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-4.71%
WINT - RNAC
94%
Closely correlated
-11.51%
NCNA - RNAC
92%
Closely correlated
-5.57%
CDTX - RNAC
92%
Closely correlated
-2.99%
NBY - RNAC
91%
Closely correlated
-1.70%
SNPX - RNAC
91%
Closely correlated
-4.22%
More